By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Positive data presented on Vermillion's OVA1 ovarian cancer test sent the company's stock up almost 27 percent in mid-afternoon trading today.

With less than two hours left to the trading day, Vermillion's shares were trading at $3.10 and went as high as $3.50 earlier in the day. More than 1.1 million shares traded hands, a greater-than-seven-fold increase from the three-month average daily volume of 152,623.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.